All Stories

  1. Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung

    Article • OncoTargets and Therapy, November 2018, Dove Medical Press

    Shun Lu, Agnieszka Cseh

  2. Afatinib/erlotinib

    Article • Reactions Weekly, November 2018, Springer Science + Business Media

    Agnieszka Cseh